See drug risks in real time

Good morning! This is where 54,109 cool kids get their AI updates. Let’s explore together. 😎

What’s up? The U.S. Food and Drug Administration has launched a new AI-powered platform that lets the public see reports of side effects from medicines, vaccines, cosmetics, and other products in real time.

How does it work? The system, called the FDA Adverse Event Monitoring System (AEMS), replaces several older databases that previously handled millions of reports about negative or unexpected health effects. Instead of information being spread across seven separate systems, AEMS gathers everything into one platform. AI helps process reports from doctors, manufacturers, consumers, and medical facilities, organizing the data and publishing updates online as they happen. The new system also simplifies how reports are submitted and searched, allowing people to quickly look up products and see whether others have reported problems. The FDA processes roughly 6–7 million reports each year, and the new system is designed to handle that data more efficiently.

Why should you care? AEMS could make drug and product safety much more transparent. By giving researchers and consumers faster access to safety reports, potential problems may be spotted sooner. The FDA also expects the system to reduce costs and encourage more people to report side effects that previously went unreported.

What’s happening? Nvidia is developing a new open-source platform called NemoClaw that lets companies deploy AI agents to complete tasks for employees.

Want some details? NemoClaw would allow businesses to send AI agents to handle work such as research, data processing, or completing multi-step digital tasks for staff. According to reports, Nvidia has begun discussing the platform with large enterprise software companies including Salesforce, Cisco, Google, Adobe, and CrowdStrike. Because the system is expected to be open source, companies could use it for free and contribute improvements to the project. The platform is also expected to include built-in security and privacy protections, which could help organizations safely use AI agents in everyday business operations.

Why does this matter? It’s clear that AI is moving beyond chatbots and into tools that can actually perform work. Instead of just answering questions, AI agents can plan steps, use software, and complete tasks on behalf of people. If widely adopted, platforms like NemoClaw could automate large portions of office work and reshape how businesses operate.

Hi — I’m Hunter, a PhD candidate whose work has appeared in major academic journals and popular tech outlets. I founded FryAI to make staying ahead of AI clear, accessible, and fun.